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Syntaxin-3 Is Required for Melanosomal Localization
of Tyrp1 in Melanocytes
Ayaka Yatsu1, Norihiko Ohbayashi1, Kanako Tamura1 and Mitsunori Fukuda1
Melanogenic enzymes are transported by vesicular/membrane trafficking to immature melanosomes in
melanocytes where they catalyze the synthesis of melanin pigments. Although several factors involved in
melanogenic enzyme trafficking have been identified in the past decade, involvement of the SNARE (soluble
N-ethylmaleimide-sensitive factor attachment protein receptor) proteins, which generally mediate membrane
fusion, on melanosomes in the process of melanogenic enzyme trafficking has never been investigated. In this
study we identified syntaxin-3, which was originally described as a target SNARE protein at the plasma membrane,
as a melanosome-resident protein and investigated whether syntaxin-3 is involved in the trafficking of the
melanogenic enzyme Tyrp1 (tyrosinase-related protein 1) in mouse melanocytes. The results showed that
knockdown of endogenous syntaxin-3 protein in melanocytes caused a dramatic reduction in Tyrp1 signals,
especially from peripheral melanosomes, presumably as a result of lysosomal degradation of Tyrp1. They also
showed that syntaxin-3 interacts with another target SNARE SNAP23 (synaptosome-associated protein of 23kDa)
and with vesicle SNARE VAMP7 (vesicle-associated membrane protein 7), which has been shown to be localized
at Tyrp1-containing vesicles/organelles. These findings suggested that the SNARE machinery composed of VAMP7
on Tyrp1-containing vesicles and syntaxin-3 and SNAP23 on melanosomes regulates Tyrp1 trafficking to the
melanosome in melanocytes.
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INTRODUCTION
Pigmentation of the skin is an important biological activity that
protects the human body from harmful UVR. Pigmentation
of mammalian skin is achieved by a series of complicated
processes that occur in melanocytes, which are specialized
melanin-producing cells localized in the basal layer of the
epidermis. Melanin pigments are first synthesized and stored
in melanosomes, specialized organelles that are produced
around the nucleus in a series of stages (i.e., stages I–IV)
(Raposo and Marks, 2007). Mature melanosomes are
transported to the cell periphery along two cytoskeletal
components, i.e., microtubules and actin filaments, and then
anchored to the plasma membrane (Fukuda, 2005; Ohbayashi
and Fukuda, 2012). The mature melanosomes are eventually
transferred from the dendrites of the melanocytes to
neighboring keratinocytes, which results in pigmentation of
the skin (Van Den Bossche et al., 2006). All of these
intracellular and intercellular processes are thought to be
required for efficient skin pigmentation in mammals, because
dysfunction of any one of them has been shown to cause
pigmentation disorders in humans and coat color variations
in mammals (Tomita and Suzuki, 2004; Di Pietro and
Dell’Angelica, 2005). Genetic and biochemical analyses of
gene products of these pigmentation disorders in the past
decade have revealed key players in melanogenesis, e.g.,
biogenesis of lysosome-related organelles complexes (BLOCs)
(Dell’Angelica, 2004) and adaptor protein complexes
(Dell’Angelica, 2009; Delevoye et al., 2009) in melanosome
biogenesis, a Rab27A–Slac2-a/melanophilin–myosin Va com-
plex in actin-dependent melanosome transport (Fukuda,
2005), and a melanoregulin (or Rab36)–RILP–dynein motor
complex in microtubule-dependent retrograde melanosome
transport (Ohbayashi et al., 2012; Matsui et al., 2012).
Melanin synthesis occurs exclusively within melanosomes,
which are specialized lysosome-related organelles, and three
melanogenic enzymes, tyrosinase, tyrosinase-related protein 1
(Tyrp1; originally called Trp1), and dopachrome tautomerase
(Dct; also called Trp2), have been shown to catalyze the
melanin synthesis pathway (Hearing, 2005). Mutations in the
gene encoding TYR and in the gene encoding TYRP1 cause
OCA1 (oculocutaneous albinism type 1) and OCA3,
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respectively, in humans (Tomita and Suzuki, 2004). None of
these enzymes is present in melanosomes in the primitive
stage (i.e., stage I); they are transported to melanosomes in a
later stage of development (i.e., stages II and III) via vesicular/
membrane trafficking. Thus, defects in this trafficking pathway
also cause pigmentation disorders in humans and coat color
variations in mice, e.g., Hermansky–Pudlak syndrome and the
corresponding murine model (Di Pietro and Dell’Angelica,
2005; Wei, 2006). BLOCs (Dell’Angelica, 2004) and adaptor
protein complexes (Dell’Angelica, 2009; Delevoye et al.,
2009), most of which are associated with Hermansky–Pudlak
syndrome, are thought to be key factors in the endosomal
transport systems of melanogenic enzymes (from early endo-
somes to melanosomes), and two small GTPases, Rab32 and
Rab38, have been shown to regulate the transport of melano-
genic enzymes (Wasmeier et al., 2006; Bultema et al., 2012).
We recently identified Varp (VPS9-ankyrin-repeat protein)
as a Rab32/38 effector involved in Tyrp1 trafficking to
melanosomes in melanocytes (Tamura et al., 2009;
Tamura et al., 2011). Interestingly, Varp also interacts with
VAMP7 (vesicle-associated membrane protein 7)/TI-VAMP
(Burgo et al., 2009) and this interaction has been shown
to be required for proper Tyrp1 trafficking to melanosomes
in melanocytes (Tamura et al., 2011). As members of
the VAMP family generally function as vesicle-soluble
N-ethylmaleimide-sensitive factor attachment protein receptor
(v-SNARE) that forms a stable complex with its cognate two (or
three) target SNAREs (t-SNAREs) and the resulting complex
functions as a general fusion machinery (Jahn and Scheller,
2006; Malsam et al., 2008), VAMP7 on Tyrp1-containing
vesicles is likely to function as a v-SNARE that mediates their
fusion with melanosomes in concert with specific t-SNAREs
localized at melanosomes. However, involvement of specific
t-SNAREs in the transport of melanogenic enzymes in
melanocytes has never been investigated.
In this study we investigated the melanosomal localization of
t-SNARE syntaxin-3 and its involvement in Tyrp1 trafficking in
melanocytes. The results showed that when syntaxin-3 or either
of its binding partners, VAMP7 (Galli et al., 1998) and SNAP23
(synaptosome-associated protein of 23 kDa) (Ravichandran
et al., 1996), was knocked down, Tyrp1 signals disappeared
from peripheral melanosomes. The possible involvement of
the SNARE machinery in Tyrp1 trafficking to the melanosomes
in melanocytes is discussed based on our findings.
RESULTS
Identification of t-SNARE syntaxin-3 on melanosomes in
melanocytes
To identify t-SNAREs on melanosomes, we searched for
candidate t-SNAREs by a bioinformatics approach. Chi et al.
(2006) reported the results of proteomic analyses of proteins
localized in stage II melanosomes from human melanoma
cells (MNT-1), and they listed syntaxin-3 as a melanosome-
resident protein in their report. To determine whether syn-
taxin-3 was endogenously expressed in mouse melanocytes
(melan-a cells), we performed immunoblot analyses with a
specific antibody. As shown in Figure 1a, syntaxin-3 expression
was clearly observed in melan-a cells (lane 2, top panel)
and its expression level was much higher than in neuroendo-
crine PC12 cells (lane 1, top panel). In contrast, neither
syntaxin-1 expression nor syntaxin-4 expression was observed
in melan-a cells, and syntaxin-2 was expressed at almost the
same level in both melan-a cells and PC12 cells (Figure 1a,
middle three panels). Next, we attempted to determine the
subcellular localization of endogenous syntaxin-3 in melan-a
cells by using the same antibody, but were unable to do so,
because it was impossible to use the antibody for an
immunofluorescence analysis. To overcome this problem,
we expressed Myc-syntaxin-3 in melan-a cells and investi-
gated its localization by confocal fluorescence microscopy.
Myc-syntaxin-3 exhibited a punctate pattern throughout the
cell in addition to the plasma membrane, and it often over-
lapped melanosomes (43.0±2.9% of syntaxin-3 colocalized
with melanosomes), where Tyrp1-containing vesicles were
targeted (yellow dots in the inset of Figure 1b, left panels,
arrowheads). We also investigated the subcellular localization
of syntaxin-2, which is also endogenously expressed in melan-
a cells, by expressing Myc-syntaxin-2. Interestingly, however,
no clear melanosomal localization of syntaxin-2 was observed
in melan-a cells (22.1±2.5% of syntaxin-2 colocalized with
melanosomes; Figure 1b, right panels).
To confirm the melanosomal localization of syntaxin-3 at
the endogenous protein level, we biochemically isolated
melanosomes with anti-tyrosinase antibody and analyzed the
melanosomal fraction by immunoblotting. As anticipated,
syntaxin-3 was copurified with tyrosinase, Tyrp1, and Rab27A
(melanosome markers), but neither was copurified with
transferrin receptor (a recycling endosome marker), lysoso-
mal-associated membrane protein 1 (LAMP-1; a lysosome
marker), or b-COP (a Golgi marker) (Figure 2).
Functional involvement of syntaxin-3 in Tyrp1 trafficking in
melanocytes
To determine whether syntaxin-3 on melanosomes is involved
in trafficking of melanogenic enzymes in melanocytes, we
knocked down endogenous syntaxin-3 protein by expressing
a specific short hairpin RNA (shRNA; Figure 3c, top panel,
lane 2) and evaluated the effect of the knockdown on the
subcellular distribution and signals of Tyrp1. Interestingly, the
immunofluorescence analyses revealed a dramatic reduc-
tion in Tyrp1 signals in the syntaxin-3-knockdown cells
(Figure 3a, middle panels, and Figure 3b), whereas no such
reduction was observed in the control cells (Figure 3a, left
panels). The reduced level of Tyrp1 protein in the syntaxin-3-
knockdown cells was confirmed by immunoblotting
(Figure 3c, second panel). This phenotype could not be
attributed to an off-target effect of the shRNAs used, because
re-expression of an shRNA-resistant form of syntaxin-3SR
(Figure 3d, lane 4) in syntaxin-3-deficient cells completely
restored the peripheral distribution of Tyrp1 (Figure 3a, right
panels, and Figure 3b). It should be noted that similar
reductions in Tyrp1 signals have been reported in melanocytes
lacking one of the Tyrp1 trafficking machineries (e.g., Rab32/
38 and their effector Varp) (Wasmeier et al., 2006; Tamura
et al., 2009; Bultema et al., 2012). Interestingly, a similar
reduced level of expression of another melanogenic enzyme,
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tyrosinase, was also observed in syntaxin-3-knockdown cells
(Figure 3c, e, and f), although expression and localization of
the lysosomal proteins LAMP-1 and cathepsin B was unaf-
fected by syntaxin-3 knockdown (Supplementary Figure S1a–c
online). Consistent with the reduced level of melanogenic
enzymes, there was a significant reduction in the melanin
content of the syntaxin-3-siRNA (small interfering RNA)-
treated cells, in comparison with the control siRNA-treated
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Figure 2. Syntaxin-3 is present on melanosomes. Immunoaffinity purification
of melanosomes with anti-tyrosinase IgG-conjugated magnetic beads (lane 3)
was performed as described in Materials and Methods. Purified melanosomal
fractions were analyzed by 10% SDS-PAGE followed by immunoblotting with
the antibodies indicated. Note that syntaxin-3 and its binding partner SNAP23
(synaptosome-associated protein of 23 kDa) were co-purified with three
melanosome markers (i.e., tyrosinase, tyrosinase-related protein 1 (Tyrp1), and
Rab27A), but essentially not copurified with transferrin receptor (TfR, a
recycling endosome marker), lysosomal-associated membrane protein 1
(LAMP-1, a lysosome marker), or b-COP (a Golgi marker). Input
for melanogenic enzymes and others means 0.1% and 0.5%, respectively,
of the volume of the reaction mixture used for immunoprecipitation
(lane 1). The amounts of IgG light chain (LC) used for immunoprecipitation
(IP) were almost the same (bottom panel) based on the results of amido black
staining of the blots.
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Figure 1. Expression and localization of syntaxin-3 in melanocytes.
(a) Endogenous expression of syntaxin-3 in melanocytes as revealed by
immunoblotting with specific antibody. Total cell lysates (10mg each) of PC12
cells (lane 1), melan-a cells (lane 2), and MDCK cells (lane 3; positive control
for anti-syntaxin-4 antibody) were subjected to 10% SDS-PAGE followed by
immunoblotting with the antibodies indicated. (b) Melanosomal localization of
syntaxin-3 in melanocytes. Melan-a cells were transfected with pCMV-Myc-
syntaxin-3 (left panels) or pCMV-Myc-syntaxin-2 (right panels) and then stained
with anti-Myc tag antibody. A typical image of the cell (top panels) and its
corresponding bright-field image (bottom panels) are shown. Melanosomes in
the bright-field image were pseudo-colored in green and merged with the Myc-
syntaxin-2/3 staining image (middle panels). The insets show magnified views
of the boxed area. Scale bars¼20mm.
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Figure 4. Lysosomal protease-dependent degradation of tyrosinase-related protein 1 (Tyrp1) in SNARE (soluble N-ethylmaleimide-sensitive factor
attachment protein receptor)-deficient melanocytes. (a) Melan-a cells that had been transfected with pSilencer-syntaxin-3 (pSilencer-VAMP7 or pSilencer-
SNAP23) together with pmStrawberry-C1 (pmStr-C1) as a transfection marker were treated with either DMSO (control), MG132 (a proteasome inhibitor), or
E64d and pepstatin A (PepA; lysosomal protease inhibitors) and stained with anti-Tyrp1 antibody. Scale bars¼ 20mm. (b–d) Quantification of the Tyrp1
signals shown in a and in Supplementary Figure S2 online. The bars represent the means and SEM of data from three independent dishes (n430). **Po0.01
(Student’s unpaired t-test) compared with the mock control (pSilencer vector alone); NS, not significant. Typical images of VAMP7 (vesicle-associated
membrane protein 7)-deficient cells and SNAP23 (synaptosome-associated protein of 23 kDa)-deficient cells that had been treated with protease inhibitors
are shown in Supplementary Figure S2 online. a.u., arbitrary unit; shRNA, short hairpin RNA.
Figure 3. Syntaxin-3 is required for proper tyrosinase-related protein 1 (Tyrp1; and tyrosinase) trafficking to melanosomes in melanocytes. (a) Knockdown
of syntaxin-3 in melan-a cells caused a dramatic reduction in Tyrp1 signals. Scale bars¼ 20mm. (b) Quantification of the Tyrp1 signals shown in a. The bars
represent the means and SEM of data from three independent dishes (n430). (c) Reduction in the level of Tyrp1 protein and tyrosinase protein in syntaxin-3-
knockdown melan-a cells as revealed by immunoblotting. (d) Characterization of a short hairpin RNA (shRNA)-resistant (SR) syntaxin-3SR mutant. (e) Knockdown
of syntaxin-3 in melan-a cells caused a dramatic reduction in tyrosinase signals. (f) Quantification of the tyrosinase signals shown in e. (g) Reduced melanin
content in syntaxin-3-siRNA-treated, VAMP7-siRNA-treated, and SNAP23-siRNA-treated melanocytes. *Po0.05; **Po0.01; NS, not significant (Student’s
unpaired t-test). a.u., arbitrary unit; EGFP, enhanced green fluorescent protein; siRNA, small interfering RNA; SNAP23, synaptosome-associated protein of
23 kDa; VAMP7, vesicle-associated membrane protein 7.
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cells (Figure 3g). These results indicated that syntaxin-3 is an
essential component of trafficking of both Tyrp1 and tyrosi-
nase in melanocytes.
Lysosomal protease-dependent degradation of Tyrp1 in
syntaxin-3-deficient melanocytes
We previously showed that the reduced Tyrp1 signals in Varp-
deficient melanocytes were clearly rescued by treatment with
a proteasome inhibitor, MG132, but not with lysosomal
protease inhibitors (E64d and pepstatin A) (Tamura et al.,
2009), indicating that Tyrp1 protein in Varp-deficient cells is
degraded by proteasomes and not by lysosomes. To determine
whether the reduced Tyrp1 signals in syntaxin-3-deficient
melanocytes are also attributable to proteasomal degra-
dation, the cells were treated with either MG132 or
lysosomal protease inhibitors (Figure 4). Unexpectedly, how-
ever, treatment of the syntaxin-3-deficient cells with MG132
did not restore Tyrp1 signals, despite the fact that treatment of
Varp-deficient cells with MG132 restores Tyrp1 signals
(Tamura et al., 2009). Instead, treatment of the syntaxin-3-
deficient cells with the lysosomal protease inhibitors restored
Tyrp1 signals, suggesting that Tyrp1 protein, which is unable
to target melanosomes because of the deficiency in syntaxin-3
function, is specifically degraded by lysosomes (Figure 4a, far
right panels, and Figure 4b).
Syntaxin-3 interacts with v-SNARE VAMP7 and t-SNARE
SNAP23 in melanocytes
In the final set of experiments, we attempted to determine
whether syntaxin-3 interacts with two other SNAREs (v-SNARE
and an additional t-SNARE) to form a SNARE complex in
melanocytes. To do so, we first focused on VAMP7, a cognate
v-SNARE VAMP7 (Galli et al., 1998), which has also been
demonstrated to regulate Tyrp1 trafficking in melanocytes
(Tamura et al., 2011). We performed co-immunopreci-
pitation assays to investigate whether VAMP7 and syntaxin-3
actually form a complex in melanocytes. As anticipated,
both recombinant and endogenous VAMP7 and syntaxin-3
molecules were copurified with each other from lysates of
melan-a cells (Figure 5a and b, middle panels). Furthermore,
the results of the immunofluorescence analyses revealed that
syntaxin-3 and VAMP7 often overlapped on the melanosomes
or in their vicinity (Figure 5c, arrowheads; 57.9±4.7%
colocalization). It should be noted that knockdown of VAMP7
phenocopied syntaxin-3-deficient melanocytes: knockdown of
VAMP7 resulted in a dramatic reduction in Tyrp1 signals and
treatment of the VAMP7-deficient cells with the lysosomal
protease inhibitors, but not with MG132, restored Tyrp1
signals (Figure 4c and Supplementary Figure S2a online).
To identify another candidate t-SNARE on melanosomes,
we next turned our attention to SNAP23 and SNAP25,
because both of them have been reported to be enriched in
melanosomal fractions of melanocytes (Scott and Zhao, 2001).
Consistent with the previous finding that SNAP23 is
ubiquitously expressed (Ravichandran et al., 1996),
predominant expression of SNAP23 was observed in melan-
a cells (Figure 6a, lane 2), whereas SNAP25, a neuron-specific
isoform, was expressed only in PC12 cells, and was not
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Figure 5. Syntaxin-3 interacts with VAMP7 (vesicle-associated membrane
protein 7) and SNAP23 (synaptosome-associated protein of 23 kDa) in
melanocytes. (a, b) Syntaxin-3, SNAP23, and VAMP7 form a SNARE (soluble
N-ethylmaleimide-sensitive factor attachment protein receptor) complex in
melanocytes. Melan-a cells that had been transfected with (a) pEF-FLAG-
VAMP7, a control pEF-BOS vector, (b) or nothing, were treated with 1 mM
N-ethylmaleimide in phosphate-buffered saline for 15 minutes on ice,
incubated in culture medium with 1 mM N-ethylmaleimide for 30 minutes at
37 1C, and then harvested. Associations between these three SNAREs were
investigated by performing co-immunoprecipitation assays as described in
Materials and Methods. Input means 1% of the volume of the reaction mixture
used for immunoprecipitation (IP). (c) Partial colocalization between syntaxin-
3 and VAMP7 in melanocytes. Typical images of the cells, merged images, and
corresponding bright-field images are shown. The insets show magnified views
of the boxed areas. Scale bar¼20mm.
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detectable in melan-a cells under our experimental conditions
(Figure 6a, lane 1). Actually, SNAP23 was copurified with
mature melanosomes together with syntaxin-3 (Figure 2). The
results of the co-immunoprecipitation assays indicated that
SNAP23 formed a complex with syntaxin-3 and VAMP7
(Figure 5a and b, bottom panels). Most strikingly, knockdown
of SNAP23 also phenocopied syntaxin-3-deficient melano-
cytes: knockdown of SNAP23 resulted in a dramatic reduction
in Tyrp1 signals, and treatment of the SNAP23-deficient cells
with the lysosomal protease inhibitors, but not with MG132,
restored Tyrp1 signals (Figure 4d and Supplementary
Figure S2b online). This phenotype could not be attributed to
an off-target effect of the SNAP23 shRNA, because re-expres-
sion of SNAP23SR (Figure 6e, lane 4) in SNAP23-deficient cells
completely restored the peripheral distribution of Tyrp1
(Figure 6b, right panels, and Figure 6c). Taken together, these
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Figure 6. SNAP23 (synaptosome-associated protein of 23 kDa) is required for proper tyrosinase-related protein 1 (Tyrp1) trafficking to melanosomes in
melanocytes. (a) Differing expression of SNAP23 and SNAP25 in PC12 cells and melan-a cells. Total cell lysates (10mg each) of PC12 cells (lane 1) and
melan-a cells (lane 2) were subjected to 10% SDS-PAGE followed by immunoblotting with the antibodies indicated. (b) Knockdown of SNAP23 in melan-a cells
caused a dramatic reduction in Tyrp1 signals. Scale bars¼ 20mm. (c) Quantification of Tyrp1 signals shown in b. The bars represent the means and SEM of
data from three independent dishes (n430). **Po0.01 (Student’s unpaired t-test) compared with the mock control (enhanced green fluorescent protein
(EGFP)). a.u., arbitrary unit; NS, not significant. (d) Reduction in the level of Tyrp1 protein in SNAP23-knockdown melan-a cells as revealed by immunoblotting.
(e) Characterization of a short hairpin RNA (shRNA)-resistant (SR) SNAP23SR mutant.
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results indicated that syntaxin-3, SNAP23, and VAMP7 all
function at the same step of Tyrp1 trafficking to melanosomes
in melanocytes, most likely by forming a SNARE complex.
DISCUSSION
Melanogenic enzymes are integral membrane proteins that are
transported to melanosomes via vesicular/membrane traffick-
ing. Although several key factors, including BLOCs
(Dell’Angelica, 2004), adaptor protein complexes
(Dell’Angelica, 2009; Delevoye et al., 2009), and Rabs
(Wasmeier et al., 2006; Tamura et al., 2011; Bultema et al.,
2012), have been shown to regulate the trafficking of
melanogenic enzymes, involvement of t-SNAREs on
melanosomes in the process of trafficking of melanogenic
enzymes to melanosomes has never been investigated. In this
study we were able to obtain several lines of evidence that
the t-SNARE syntaxin-3 is involved in Tyrp1 trafficking to
melanosomes in melanocytes. First, we identified syntaxin-3
on melanosomes in melanocytes (Figures 1 and 2). Second,
we demonstrated that knockdown of endogenous syntaxin-3
protein in melanocytes caused a dramatic reduction in Tyrp1
signals (Figure 3), the same as had been demonstrated by
knockdown of each component of the Varp–Rab32/38 com-
plex (Wasmeier et al., 2006; Tamura et al., 2009; Tamura
et al., 2011; Bultema et al., 2012), which is also involved in
Tyrp1 trafficking to melanosomes. The reduction in Tyrp1
signals is attributable to degradation of Tyrp1 protein
(Figure 3c), because lysosomal protease inhibitors, but not a
proteasome inhibitor MG132, blocked the disappearance of
Tyrp1 signals in syntaxin-3-deficient melanocytes (Figure 4).
Similar lysosome-dependent degradation of Tyrp1 was also
reported in BLOC-1-deficient cells (Di Pietro et al., 2006).
What is the function of syntaxin-3 on melanosomes in Tyrp1
trafficking? As a cognate v-SNARE VAMP7 has been shown
to be localized on Tyrp1-containing vesicles (Tamura et al.,
2011) and knockdown of VAMP7 (or another t-SNARE
SNAP23) phenocopied the syntaxin-3-deficient cells
(Figures 4 and 6, and Supplementary Figure S2 online), the
most plausible function of syntaxin-3 in melanocytes is a
mediator of fusion between Tyrp1-containing vesicles/orga-
nelles by forming a complex with VAMP7 and SNAP23.
Actually, interaction between syntaxin-3, SNAP23, and
VAMP7 in melanocytes was easy to detect by co-immuno-
precipitation assays (Figure 5a and b).
Although Tyrp1 protein in SNARE-deficient cells was
degraded in a lysosomal protease-dependent manner
(Figure 4), we previously showed that disappearance of Tyrp1
signals in Varp-deficient cells was blocked by treatment with
MG132, but not by treatment with lysosomal protease
inhibitors (Tamura et al., 2009). The reason for this discre-
pancy can be explained by the following model. Tyrp1-
containing vesicles/organelles are initially transported by the
Varp–Rab32/38 complex. Deficiency of any one of the
members of the complex results in disappearance of Tyrp1
protein due to proteasome-mediated protein degradation. The
Varp–Rab32/38 complex also interacts with VAMP7 on Tyrp1-
containing vesicles, and this interaction may ensure the
loading of v-SNARE on Tyrp1-containing vesicles and may
also keep VAMP7 in a fusogenically inactive conformation
(Scha¨fer et al., 2012). When the Tyrp1-containing vesicles
reach their target organelle, i.e., stage II/III melanosomes,
VAMP7 is released from Varp by an unknown mechanism,
and a SNARE complex is formed between VAMP7 (on the
Tyrp1-containing vesicle) and two t-SNAREs, syntaxin-3 and
SNAP23 (on the melanosome), leading to fusion between the
two membranes. As a result, Tyrp1 protein is transported to
the melanosome, thereby enabling successful melanin
synthesis (i.e., formation of a stage IV melanosome). Based
on our findings, we propose that the mechanism of quality
control of Tyrp1 protein differs depending on the step of the
Tyrp1 trafficking pathway, i.e., that an early step of Tyrp1
trafficking, which is mediated by the Varp–Rab32/38 complex,
is controlled by proteasomes, and that a later step of Tyrp1
trafficking, which is mediated by the SNARE complex (or the
BLOC-1 complex), is controlled by lysosomal degradation. In
contrast to syntaxin-3 and SNAP23, however, VAMP7 has an
additional function that regulates LAMP-1 transport (Pols et al.,
2013). Actually, knockdown of VAMP7, but not of syntaxin-3
or SNAP23, decreased the amount of LAMP-1 in melanocytes
(Supplementary Figure S1c online). Thus, VAMP7 has at least
two functions in melanocytes: regulation of LAMP-1 transport
independently of syntaxin-3 and SNAP23, and regulation of
Tyrp1 transport in concert with syntaxin-3 and SNAP23.
In summary, we demonstrated that t-SNARE syntaxin-3 on
melanosomes is required for transport of a melanogenic
enzyme, Tyrp1, to melanosomes. In the absence of syntaxin-
3 (or its binding partners, VAMP7 and SNAP23), Tyrp1
protein would be mistargeted to lysosomes and degraded by
lysosomal proteases. As syntaxin-3 is also required for
trafficking of another melanogenic enzyme, tyrosinase, to
melanosomes, the SNARE machinery composed of syntaxin-
3, SNAP23, and VAMP7 most likely functions as a general
regulator of melanogenic enzyme trafficking to melanosomes
in melanocytes.
MATERIALS AND METHODS
Antibodies
Anti-syntaxin-3 rabbit polyclonal antibody, anti-syntaxin-2 rabbit
antiserum, and anti-SNAP23 rabbit antiserum were obtained from
Synaptic Systems (Go¨ttingen, Germany). Anti-b-actin mouse mAb,
anti-transferrin receptor mouse mAb, anti-LAMP-1 rabbit polyclonal
antibody, and anti-b-COP rabbit polyclonal antibody were from
Applied Biological Materials (Richmond, Canada), Invitrogen (Carls-
bad, CA), BD Biosciences (San Jose, CA), and Merck KGaA (Darm-
stadt, Germany), respectively. Horseradish peroxidase–conjugated
anti-Myc tag mouse mAb and anti-green fluorescent protein rabbit
polyclonal antibody were from MBL (Nagoya, Japan). Anti-Tyrp1 goat
polyclonal antibody, anti-Tyrp1 mouse mAb (Ta99), anti-syntaxin-1
mouse mAb (HPC-1), anti-cathepsin B goat polyclonal antibody
(S-12), and anti-Myc tag mouse mAb (9E10) were from Santa
Cruz Biotechnology (Santa Cruz, CA). Anti-SNAP25 mouse mAb,
horseradish peroxidase–conjugated anti-FLAG tag (M2) mouse mAb,
anti-FLAG tag rabbit polyclonal antibody, and anti-Myc tag rabbit
polyclonal antibody were obtained from Sigma-Aldrich (St Louis,
MO). Alexa 488/594-conjugated anti-mouse, anti-rabbit, and anti-
goat IgG goat/donkey antibodies were from Invitrogen. Anti-tyrosinase
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rabbit polyclonal antibody and anti-Rab27A rabbit polyclonal anti-
body were prepared as described previously (Saegusa et al., 2006;
Beaumont et al., 2011). Anti-Tyrp1 rabbit polyclonal antibody and
anti-VAMP7 rabbit polyclonal antibody were raised against a peptide
corresponding to the C-terminal sequence (amino acid residues
524–537) of mouse Tyrp1 (Jime´nez et al., 1991) and the N-terminal
domain of mouse VAMP7 (amino acid residues 1–360), respectively,
with glutathione S-transferase, and then affinity-purified with antigen-
immobilized beads essentially as described previously (Fukuda and
Mikoshiba, 1999).
Plasmid construction
The complementary DNAs of mouse syntaxin-2, syntaxin-3, and
VAMP7 were prepared as described previously (Fukuda et al., 2005;
Tamura et al., 2011). The complementary DNA of mouse SNAP23
was amplified from melan-a complementary DNAs by PCR with
specific oligonucleotides. The complementary DNAs of syntaxin-2,
syntaxin-3, SNAP23, and VAMP7 were subcloned into the pEF-FLAG/
Myc vectors, which were modified from pEF-BOS (Fukuda et al.,
1999; Mori et al., 2012). The Myc-syntaxin-2, Myc-syntaxin-3, Myc-
SNAP23, and FLAG-VAMP7 fragments were excised from the above
pEF vectors by BglII and NotI double digestion and then subcloned
into the BglII/NotI site (i.e., removal of the whole enhanced green
fluorescent protein sequence) of the pEGFP-N2 vector (Clontech-
Takara Bio, Shiga, Japan), and the resulting vectors were referred to as
pCMV-Myc-syntaxin-2, pCMV-Myc-syntaxin-3, pCMV-Myc-SNAP23,
and pCMV-FLAG-VAMP7, respectively. pSilencer-2.1-U6 neo vectors
(Ambion, Austin, TX) encoding shRNA targeting syntaxin-3, SNAP23,
and VAMP7 were constructed as described previously (Kuroda and
Fukuda, 2004; Tamura et al., 2011): pSilencer-syntaxin-3 (target site:
50-CAGATGAGGAGCTGGAAGAG-30) and pSilencer-SNAP23 (target
site: 50-GTGGGCAGCATCCTAGGCA-30). pCMV-Myc-syntaxin-3SR
and pCMV-Myc-SNAP23SR (shRNA-resistant mutant) were produced
by a two-step PCR technique as described previously (Tamura et al.,
2009; Tamura et al., 2011). siRNAs corresponding to the target
sequences of the shRNAs of the above SNAREs were chemically
synthesized by Nippon Gene (Toyama, Japan). The stealth RNAi
RNAs against mouse SNAP23 were obtained from Invitrogen (catalog
numbers, 1062318 and 1062319).
Immunofluorescence analysis
The black-mouse-derived immortal melanocyte cell line melan-a
(generous gift of Dorothy C Bennett) was cultured as described
previously (Bennett et al., 1987; Kuroda et al., 2003). Plasmids
were transfected into melan-a cells by using FuGENE6 (Promega,
Madison, WI) according to the manufacturer’s instructions. At 2 days
after transfection, cells were fixed with 4% paraformaldehyde or ice-
cold 100% methanol, permeabilized with 0.3% Triton X-100, stained
with primary antibodies, and then visualized with Alexa 488/594-
conjugated anti-mouse, anti-rabbit, and/or anti-goat IgG goat/donkey
antibodies. Cells were exposed to a proteasome inhibitor (10mM
MG132; Peptide Institute, Osaka, Japan) for 3 hours or to lysosomal
protease inhibitors (10mM E64d and 10mg ml 1 pepstatin A;
Peptide Institute) for 6 hours before fixation. Cells were examined
for immunostaining signals with a confocal fluorescence microscope
(Fluoview; Olympus, Tokyo, Japan) as described previously (Kuroda
et al., 2003). The images were processed with Adobe Photoshop
software (CS5, San Jose, CA). To quantitatively measure Tyrp1 signals,
images of enhanced green fluorescent protein–expressing cells,
Myc-syntaxin-3SR-expressing cells, or Myc-SNAP23SR-expressing cells
were captured at random (n430 from three independent dishes) with
the confocal microscope, and the Tyrp1 fluorescent signals were
quantified with MetaMorph software (Molecular Devices, Sunnyvale,
CA). Colocalization analyses were performed with the RG2B coloca-
lization plug-in of ImageJ software (version 1.46r; NIH, Bethesda,
MD) as described previously (Matsui et al., 2011).
Immunoaffinity purification of mature melanosomes
Mature melanosomes were immunoaffinity purified with anti-tyrosi-
nase IgG-conjugated magnetic beads essentially as described pre-
viously (Kuroda and Fukuda, 2004; Ohbayashi et al., 2012).
Co-immunoprecipitation assay
Co-immunoprecipitation assays using anti-FLAG tag antibody-con-
jugated agarose beads (Sigma-Aldrich) were performed as described
previously (Fukuda and Kanno, 2005). Immunoprecipitated FLAG-
VAMP7 and co-immunoprecipitated endogenous syntaxin-3 and
SNAP23 were detected by immunoblotting with specific antibodies.
Endogenous SNARE complex composed of syntaxin-3, SNAP23, and
VAMP7 was similarly co-immunoprecipitated from lysates of melan-a
cells that had been treated with 1 mM N-ethylmaleimide (Wako Pure
Chemical Industries, Osaka, Japan) by using anti-syntaxin-3 antibody.
Protein-A Sepharose beads were obtained from GE Healthcare (Little
Chalfont, UK).
Melanin assay
Melan-a cells that had been transfected with siRNAs were cultured for
4 days and harvested. The melanin content of the transfected cells
was measured as optical density at 490 nm and normalized to their
protein content as described previously (Tamura et al., 2009). The
results are expressed as the means and SEM of data from five
independent experiments (Figure 3g).
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